Nebius Beats Wall Street Expectations as AI Cloud Deals and Capacity Surge in Q2
Nebius beats Q2 revenue estimates at $582.3M (+454% YoY) with record AI cloud deals and raised 5 GW capacity target.
NOTRELOAD AI
Nokia Shares Rally as U.S. Eyes Ban on Chinese Optical Transceivers
Nokia shares climb after reports the FCC may ban new Chinese optical transceivers, positioning the company as a winner in the AI data-center buildout.
Definium’s Experimental LSD Drug Delivers Strong Phase 3 Results in Anxiety Trial
Definium’s one-dose anxiety drug cut symptoms for 12 weeks, with mostly mild side effects, offering hope for a new treatment.
UAMY Stock Falls After Q2 Revenue Miss and Sharp Guidance Cut
Q2 revenue of $7.9M missed estimates, while 2026 guidance was cut to $60–75M from $125M due to weak antimony prices.
Velo3D Surges Nearly 20% on 52% Revenue Growth and Higher 2026 Outlook
Velo3D deepens partnerships with Mears Machine and Aurelia Technologies while supporting SpaceX as a major metal 3D printing supplier for aerospace and space programs.
MGNX Rises After Gilead Exercises Option on Bispecific Program
Gilead pays MacroGenics $10 million to license a TRIDENT-based bispecific for solid tumors, extending its cash runway to 2028.